Applied Biocode | GenomeWeb

Applied Biocode

The companies will use their respective technologies to develop multiplex molecular diagnostic panels for laboratory testing.

The deal covers use within the life sciences, food and beverage research, and environmental testing markets.

The deal provides PerkinElmer access to Applied BioCode's Barcoded Magnetic Bead technology, including the BioCode MDx 3000 instrument.

Genetic Analysis CEO Kari Stenersen said the deal is a "commercial breakthrough" for the Oslo-based company.

NEW YORK (GenomeWeb) — Applied BioCode is developing a new test for gastrointestinal pathogens that it hopes to sell to high-volume hospital laboratories and that will compete directly with Luminex's US Food and Drug Administration-cleared Gastrointestinal Pathogen Panel.

Genetic Analysis said this week that its GA-map IBS Dysbiosis test is now CE marked and available for use on clinical samples in European labs.

NEW YORK (GenomeWeb News) – Applied BioCode today said it has signed a license and supply agreement covering its barcoded magnetic bead (BMB) technology with molecular diagnostics firm Genetic Analysis.

Illumina this week named Charles Dadswell as senior vice president and general counsel.

Illumina has appointed Charles Dadswell as its new senior vice president and general counsel. Dadswell replaces Christian Cabou, who has retired, and is responsible for all of the company's legal and IP matters.

IntegenX this week announced the appointment of Robert Schueren as CEO.


In PLOS this week: role for Notch signaling in congenital heart disease, sciatica risk variants, and more.

Researchers in China have used the CRISPR/Cas9 genome editing approach to alter the length of hair fibers in cashmere goats.

According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.

National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.